• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非厌食、未减重的荷瘤大鼠体内谷氨酰胺耗竭与肠道通透性增加

Glutamine depletion and increased gut permeability in nonanorectic, non-weight-losing tumor-bearing rats.

作者信息

De Blaauw I, Deutz N E, van der Hulst R R, von Meyenfeldt M F

机构信息

Department of Surgery, Faculty II, University of Limburg, Maastricht, The Netherlands.

出版信息

Gastroenterology. 1997 Jan;112(1):118-26. doi: 10.1016/s0016-5085(97)70226-9.

DOI:10.1016/s0016-5085(97)70226-9
PMID:8978350
Abstract

BACKGROUND & AIMS: Glutamine is an essential amino acid for rapidly dividing cells such as enterocytes. The progress of cancer is associated with a decrease of arterial and muscle glutamine concentrations. The aim of this study was to test whether increasing tumor loads affect gut intracellular glutamine handling, protein turnover, and gut absorptive and barrier function.

METHODS

Methylcholantrene-induced tumor-bearing rats were studied with a subcutaneous tumor load of 5%-15% or 15%-30% of body weight. Portal drained visceral net uptake or release of energy substrates, amino acids, and intestinal protein turnover were studied. Gut absorptive capacity and permeability was assessed by the urinary recovery of 3-O-methyl-D-glucose or lactulose-rhamnose ratio after an oral gavage.

RESULTS

In tumor-bearing rats, the net uptake of energy substrates (ketones and glutamine) and net protein synthesis increased across the portal drained viscera, whereas mucosal glutamine concentrations decreased. Absorptive capacity remained unchanged in both tumor-bearing groups. However, the lactulose-rhamnose ratio increased with increasing tumor load, indicating loss of gut barrier function. This was not related to changes in villus height, crypt depth, or changes in mucosal cell populations but to decreased intracellular polyamine concentrations.

CONCLUSIONS

The presence of a methylcholantrene tumor leads to altered mucosal glutamine metabolism and loss of gut barrier function possibly related to disturbed proliferation or differentiation of enterocytes.

摘要

背景与目的

谷氨酰胺是诸如肠上皮细胞等快速分裂细胞所必需的氨基酸。癌症进展与动脉血和肌肉中谷氨酰胺浓度降低相关。本研究旨在测试肿瘤负荷增加是否会影响肠道细胞内谷氨酰胺的处理、蛋白质周转以及肠道吸收和屏障功能。

方法

对甲基胆蒽诱导的荷瘤大鼠进行研究,皮下肿瘤负荷为体重的5%-15%或15%-30%。研究门静脉引流内脏对能量底物、氨基酸的净摄取或释放以及肠道蛋白质周转。通过口服灌胃后尿中3-O-甲基-D-葡萄糖的回收率或乳果糖-鼠李糖比率评估肠道吸收能力和通透性。

结果

在荷瘤大鼠中,门静脉引流内脏对能量底物(酮类和谷氨酰胺)的净摄取和净蛋白质合成增加,而黏膜谷氨酰胺浓度降低。两个荷瘤组的吸收能力均保持不变。然而,随着肿瘤负荷增加,乳果糖-鼠李糖比率升高,表明肠道屏障功能丧失。这与绒毛高度、隐窝深度或黏膜细胞群体的变化无关,而是与细胞内多胺浓度降低有关。

结论

甲基胆蒽肿瘤的存在导致黏膜谷氨酰胺代谢改变和肠道屏障功能丧失,这可能与肠上皮细胞增殖或分化紊乱有关。

相似文献

1
Glutamine depletion and increased gut permeability in nonanorectic, non-weight-losing tumor-bearing rats.非厌食、未减重的荷瘤大鼠体内谷氨酰胺耗竭与肠道通透性增加
Gastroenterology. 1997 Jan;112(1):118-26. doi: 10.1016/s0016-5085(97)70226-9.
2
Attenuated metabolic response to surgery in tumor-bearing rats.荷瘤大鼠对手术的代谢反应减弱。
J Surg Res. 2003 Apr;110(2):371-7. doi: 10.1016/s0022-4804(03)00041-6.
3
Altered glutamine metabolism in rat portal drained viscera and hindquarter during hyperammonemia.高氨血症期间大鼠门静脉引流内脏和后肢的谷氨酰胺代谢改变。
Gastroenterology. 1992 Mar;102(3):936-48. doi: 10.1016/0016-5085(92)90180-7.
4
Inflammation rather than nutritional depletion determines glutamine concentrations and intestinal permeability.炎症而非营养消耗决定谷氨酰胺浓度和肠道通透性。
Clin Nutr. 2004 Oct;23(5):1209-16. doi: 10.1016/j.clnu.2004.04.001.
5
Parenteral nutrition is associated with intestinal morphologic and functional changes in humans.肠外营养与人类肠道的形态和功能变化有关。
JPEN J Parenter Enteral Nutr. 1995 Nov-Dec;19(6):453-60. doi: 10.1177/0148607195019006453.
6
Effects of parenteral arginine supplementation on the intestinal adaptive response after massive small bowel resection in the rat.肠外补充精氨酸对大鼠广泛小肠切除术后肠道适应性反应的影响。
J Surg Res. 1999 Aug;85(2):259-66. doi: 10.1006/jsre.1999.5607.
7
Intestinal function and metabolism in the early adaptive phase after massive small bowel resection in the rat.大鼠大量小肠切除术后早期适应阶段的肠道功能与代谢
J Pediatr Surg. 2001 Dec;36(12):1746-51. doi: 10.1053/jpsu.2001.28813.
8
Effects of decreased glutamine supply on gut and liver metabolism in vivo in rats.谷氨酰胺供应减少对大鼠体内肠道和肝脏代谢的影响。
Clin Sci (Lond). 1993 Oct;85(4):437-44. doi: 10.1042/cs0850437.
9
Increased whole-body protein and glutamine turnover in advanced cancer is not matched by an increased muscle protein and glutamine turnover.晚期癌症患者全身蛋白质和谷氨酰胺周转率增加,但肌肉蛋白质和谷氨酰胺周转率并未相应增加。
J Surg Res. 1997 Feb 15;68(1):44-55. doi: 10.1006/jsre.1997.5007.
10
Glutamine and recombinant human growth hormone protect intestinal barrier function following portal hypertension surgery.谷氨酰胺和重组人生长激素可保护门静脉高压手术后的肠道屏障功能。
World J Gastroenterol. 2007 Apr 21;13(15):2223-8. doi: 10.3748/wjg.v13.i15.2223.

引用本文的文献

1
Glutamine as indispensable nutrient in oncology: experimental and clinical evidence.谷氨酰胺作为肿瘤学中不可或缺的营养物质:实验和临床证据。
Eur J Nutr. 2010 Jun;49(4):197-210. doi: 10.1007/s00394-009-0082-2. Epub 2009 Nov 21.
2
Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats.食欲素激素胃饥饿素可改善大鼠脓毒症时的肠道屏障功能障碍。
Crit Care Med. 2009 Aug;37(8):2421-6. doi: 10.1097/CCM.0b013e3181a557a2.
3
Effects of n-3 fatty acid, fructose-1,6-diphosphate and glutamine on mucosal cell proliferation and apoptosis of small bowel graft after transplantation in rats.
n-3脂肪酸、果糖-1,6-二磷酸和谷氨酰胺对大鼠小肠移植术后移植肠黏膜细胞增殖及凋亡的影响
World J Gastroenterol. 2003 Jun;9(6):1323-6. doi: 10.3748/wjg.v9.i6.1323.
4
Glutamine deprivation facilitates tumour necrosis factor induced bacterial translocation in Caco-2 cells by depletion of enterocyte fuel substrate.谷氨酰胺缺乏通过消耗肠上皮细胞燃料底物促进肿瘤坏死因子诱导的Caco-2细胞细菌移位。
Gut. 2003 Feb;52(2):224-30. doi: 10.1136/gut.52.2.224.
5
Clinical tests of gastrointestinal permeability that rely on the urinary recovery of enterally administered probes can yield invalid results in critically ill patients.依赖肠道给药探针经尿液回收情况的胃肠道通透性临床试验,在危重症患者中可能产生无效结果。
Intensive Care Med. 2002 Feb;28(2):103-4. doi: 10.1007/s00134-001-1191-4. Epub 2002 Jan 12.